Stock Market News2 months Merck’s ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC Zacks
This is the first breakthrough therapy designation granted to MRK’s sacituzumab tirumotecan in the United States.
XThis is the first breakthrough therapy designation granted to MRK’s sacituzumab tirumotecan in the United States.
X